Singapore: GI Dynamics, a medical device company developing treatments for type 2 diabetes and obesity, has decided to a...
Dealing with the common diseases in an innovative manner is becoming a trend these days and not surprisingly, Australia ...
Singapore: Australia-based Allied Healthcare has received CE mark approval for its regenerative product, CardioCel, allo...
Singapore, July 04, 2012: The growing elderly population and its associated disease burden add to the economic challenge...
Singapore: As a part of Australian Business Week in India (ABWI) 2015, the 19 member Australian Health and Life Sciences...
Singapore: The medical device regulators of Australia, Brazil, Canada and the US have all signed on to a statement of co...
Singapore: Research on treatment of Alzheimer's disease received a fillip with Australian scientists working on it recei...
Singapore: India generated the nearly one-fourth of the global revenue of the lifescience market in APAC. Highlig...
Singapore: Australia was the third largest contributor to the lifescience market in the region Highlights • An ...
Singapore: The University of Queensland-based biotechnology company Protagonist Therapeutics has secured $14 million in ...
Singapore: AdiStem, a provider of photo activation technology and medical solutions, highlighted that platelet rich pla...
Singapore: AusBiotech, the bioscience industry organization of Australia, has told the government that patent length in ...
Valentine's Day, which is marked as a day to commemorate the death anniversary of Saint Valentine, saw the birth of a ve...
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...
Singapore: Dr Anna Lavelle, CEO, AusBiotech, has been elected to Fellowship of the Australian Academy of Technological S...
Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, ...
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...
